Dana-Farber Cancer Institute health news articles

Bevacizumab with chemotherapy provides no survival benefit for lung cancer patients
Adding the drug bevacizumab (Avastin) to the standard chemotherapy regimen for non-small cell lung cancer (NSCLC) – an approach approved by the FDA in 2006 – did not lead to significantly increase survival rates for patients over the age of 65 enrolled in Medicare.

New technique extends cancer fighting cells' potency in melanoma patients
Researchers trained white blood cells to attack tumors tend to fade away quickly when injected into cancer patients.

Gene based prostate cancer test may make more accurate treatment decisions
Researchers conducted an elaborate series of experiments to identify the genes most closely linked to the aggressive biology of prostate cancer. They found about 300 genes that distinguished the two groups - indolent versus aggressive prostate cancers.

Radiotherapy delay increases breast cancer recurrence risk
Older women who have had breast cancer surgery have a greater risk of the cancer returning if they delay their post-surgical radiation treatment, report Dana-Farber Cancer Institute scientists.

Genes found linked to breast cancer drug resistance
Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.

New 3 drug combination for multiple myeloma patients
A new three-drug combination has shown in a phase 1/2 clinical trial that it is a "highly effective regimen" in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow, say researchers from Dana-Farber Cancer Institute.

Treating obesity with brown fat in the body
Researchers have shown that they can produce brown fat, a natural energy-burning type of fat that counteracts obesity. If such a strategy can be developed for use in people, it could open a novel approach to treating obesity and diabetes.

Selenium may worsen prostate cancer in some
Higher selenium levels in the blood may worsen prostate cancer in some men who already have the disease, revealed by researchers.

Early stem cell transplant best for acute myeloid leukemia patients
A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.

Health news organizations - D

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
6.26